Pfizer Sues Chinese Agency Over Rejected Envacar Trademark
In an opening session at the First Intermediate Court of Beijing, the U.S. drug maker maintained it twice submitted an application to the agency to register Envacar as a trademark for the drug, the Beijing Times reported.
Pfizer made its first application in September 2001, but the application was rejected on the grounds that a dictionary published by state-owned...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login